Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Liver"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1086891

Starter badań:

Tytuł:
Cell therapy in end-stage liver disease: replace and remodel.
Autorzy:
Hu XH; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China.; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Chen L; Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Wu H; NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, 310003, China.
Tang YB; NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, 310003, China.
Zheng QM; Life Sciences Institute, Zhejiang University, Hangzhou, 310058, China.
Wei XY; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Wei Q; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China.
Huang Q; Zhejiang Chinese Medical University, Hangzhou, 310053, China.
Chen J; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China. zju_.
Xu X; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, 310053, China. .; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, 310006, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 May 25; Vol. 14 (1), pp. 141. Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
End Stage Liver Disease*/therapy
End Stage Liver Disease*/metabolism
Liver Diseases*/therapy
Animals ; Humans ; Liver/metabolism ; Hepatocytes/transplantation ; Cell- and Tissue-Based Therapy ; Liver Regeneration ; Cell Differentiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liver regeneration after two-stage liver transplantation is more effective than after other preconditioning procedures in colorectal liver metastases.
Autorzy:
Ali Deeb A; Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Rauchfuß F; Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Gaßler N; Institute of Pathology, Jena University Hospital, Jena, Germany.
Dondorf F; Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Rohland O; Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Tannapfel A; Institute of Pathology, Ruhr University, Bochum, Germany.
Settmacher U; Department of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Pokaż więcej
Źródło:
Journal of hepato-biliary-pancreatic sciences [J Hepatobiliary Pancreat Sci] 2023 May; Vol. 30 (5), pp. 615-624. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Transplantation*
Liver Neoplasms*/secondary
Colorectal Neoplasms*/pathology
Humans ; Liver Regeneration ; Treatment Outcome ; Living Donors ; Liver/surgery ; Hepatectomy/methods ; Portal Vein/surgery ; Portal Vein/pathology ; Ligation
Czasopismo naukowe
Szczegóły
Tytuł:
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
Autorzy:
Younossi ZM; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Stepanova M; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, Washington, District of Columbia, USA.
Felix S; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Jeffers T; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Younossi E; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Goodman Z; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Racila A; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Lam BP; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.
Henry L; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Inova Medicine Service Line, Inova Health System, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, Washington, District of Columbia, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jun; Vol. 57 (12), pp. 1417-1422. Date of Electronic Publication: 2023 Mar 26.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Humans ; Male ; Adult ; Middle Aged ; Female ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Predictive Value of Tests ; Risk Factors ; Biopsy ; Liver/pathology ; Fibrosis
Czasopismo naukowe
Szczegóły
Tytuł:
Liver biopsy for assessment of chronic liver diseases: a synopsis.
Autorzy:
Chowdhury AB; GKT School of Medical Education, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Mehta KJ; Centre for Education, Faculty of Life Sciences and Medicine, King's College London, London, UK. .
Pokaż więcej
Źródło:
Clinical and experimental medicine [Clin Exp Med] 2023 Jun; Vol. 23 (2), pp. 273-285. Date of Electronic Publication: 2022 Feb 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/pathology
Liver Neoplasms*/pathology
Humans ; Liver Cirrhosis/pathology ; Liver/pathology ; Biopsy/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
Associations between dietary flavonoid intake with hepatic steatosis and fibrosis quantified by VCTE: Evidence from NHANES and FNDDS.
Autorzy:
Xie R; Department of Microsurgery, University of South China Affiliated Nanhua Hospital, Hengyang, China; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Medical Faculty, University of Heidelberg, 69117 Heidelberg, Germany.
Zhang Y; Department of Gland Surgery, University of South China Affiliated Nanhua Hospital, Hengyang, China. Electronic address: .
Pokaż więcej
Źródło:
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2023 Jun; Vol. 33 (6), pp. 1179-1189. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/epidemiology
Elasticity Imaging Techniques*/methods
Humans ; Nutrition Surveys ; Flavonoids/adverse effects ; Vibration ; Fibrosis ; Polyphenols ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/epidemiology ; Liver/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
Autorzy:
Prabhakar T; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Kaushal K; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Prasad M; Department of Clinical Epidemiology, Institute of Liver and Biliary Sciences, New Delhi, India.
Gupta E; Department of Virology, Institute of Liver and Biliary Science, New Delhi, India.
Sood A; Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
Jain AK; Department of Gastroenterology, Choithram Hospital and Research Centre, Indore, India.
Shukla A; Department of Gastroenterology, GS Medical College and KEM Hospital, Mumbai, India.
Goel A; Department of Hepatology, Christian Medical College, Vellore, India.
Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saraya A; Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Shah S; Department of Transplant Hepatology, HPB, Liver Intensive Care, Global Hospital, Mumbai, India.
Kumar G; Department of Biostatistics, Institute of Liver and Biliary Sciences, New Delhi, India.
Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. .
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2023 Jun; Vol. 17 (3), pp. 745-752. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Liver Neoplasms*/pathology
Non-alcoholic Fatty Liver Disease*/pathology
Hepatitis B*/complications
Humans ; Male ; Middle Aged ; Aged ; Female ; Liver Cirrhosis/etiology ; Liver Cirrhosis/complications ; Fibrosis ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Extracellular volume fraction obtained by dual-energy CT depicting the etiological differences of liver fibrosis.
Autorzy:
Ozaki K; Department of Radiology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Fukui, 910-1193, Japan. .; Department of Radiology, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-Ku, Hamamatsu, 431-3192, Japan. .
Ohtani T; Radiological Center, University of Fukui Hospital, Eiheiji, Japan.
Ishida S; Radiological Center, University of Fukui Hospital, Eiheiji, Japan.; Department of Radiological Technology, Faculty of Medical Science, Kyoto College of Medical Science, Kyoto, Japan.
Higuchi S; Department of Pathology, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.
Ishida T; Radiological Center, University of Fukui Hospital, Eiheiji, Japan.
Takahashi K; Radiological Center, University of Fukui Hospital, Eiheiji, Japan.
Matta Y; Radiological Center, University of Fukui Hospital, Eiheiji, Japan.
KImura H; Department of Radiology, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Fukui, 910-1193, Japan.
Gabata T; Department of Radiology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Pokaż więcej
Źródło:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2023 Jun; Vol. 48 (6), pp. 1975-1986. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/pathology
Liver Diseases, Alcoholic*/pathology
Humans ; Retrospective Studies ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/pathology ; Liver/pathology ; Fibrosis ; Ethanol ; Tomography, X-Ray Computed/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Autorzy:
Bertot LC; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Jeffrey GP; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
de Boer B; Department of Anatomical Pathology, Pathwest, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Wang Z; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Huang Y; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Garas G; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
MacQuillan G; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Wallace M; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Smith BW; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia.
Adams LA; Medical School, University of Western Australia, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia. .; Department of Hepatology, Sir Charles Gairdner Hospital, QEII Medical Campus, Verdun St, Nedlands, WA, 6009, Australia. .
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 Jun; Vol. 68 (6), pp. 2757-2767. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Humans ; Liver/diagnostic imaging ; Liver/pathology ; Severity of Illness Index ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/etiology ; Fibrosis ; Biomarkers ; Obesity/complications ; Obesity/pathology ; Biopsy ; Aspartate Aminotransferases
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
Autorzy:
Shelley K; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, USA.
Articolo A; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, USA.
Luthra R; Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, USA. .
Charlton M; Transplant Institute, Center for Liver Diseases, University of Chicago Biological Sciences, Chicago, IL, USA.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 May 19; Vol. 23 (1), pp. 160. Date of Electronic Publication: 2023 May 19.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/therapy
Diabetes Mellitus, Type 2*/complications
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Metformin*
Humans ; Cross-Sectional Studies ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/pathology ; Obesity/complications ; Cholesterol
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Soluble CD163 is a predictor of fibrosis and hepatocellular carcinoma development in nonalcoholic steatohepatitis.
Autorzy:
Kawanaka M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan. .
Nishino K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Kawada M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Ishii K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Tanikawa T; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Katsumata R; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Urata N; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Nakamura J; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Suehiro M; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Haruma K; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Kawamoto H; Department of General Internal Medicine, General Medical Center, Kawasaki Medical School, 2-6-1, Nakasange, Kita-ku, Okayama City, 700-8505, Okayama, Japan.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 May 10; Vol. 23 (1), pp. 143. Date of Electronic Publication: 2023 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*
Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/complications
Liver Neoplasms*/etiology
Liver Neoplasms*/complications
Male ; Humans ; Female ; Adult ; Middle Aged ; Aged ; Retrospective Studies ; Liver/pathology ; Liver Cirrhosis/complications ; Inflammation/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Liver diseases: Perspective from the Philippines.
Autorzy:
Ornos ED; College of Medicine, University of the Philippines Manila, Taft Avenue, Manila, Philippines.
Murillo KJ; Division of Gastroenterology, Department of Medicine, University of the Philippines-Philippine General Hospital, Taft Avenue, Manila, Philippines.
Ong JP; Division of Gastroenterology, Department of Medicine, University of the Philippines-Philippine General Hospital, Taft Avenue, Manila, Philippines. Electronic address: .
Pokaż więcej
Źródło:
Annals of hepatology [Ann Hepatol] 2023 May-Jun; Vol. 28 (3), pp. 101085. Date of Electronic Publication: 2023 Mar 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Liver Diseases, Alcoholic*/diagnosis
Liver Diseases, Alcoholic*/epidemiology
Liver Diseases, Alcoholic*/complications
Carcinoma, Hepatocellular*
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/therapy
Liver Neoplasms*/epidemiology
Liver Neoplasms*/therapy
Liver Neoplasms*/complications
Humans ; Philippines/epidemiology ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/etiology ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
Autorzy:
Jindal A; Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India, 110070.
Agarwal S; Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India, 110029.
Sharma S; Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India, 110029.
Kumar M; Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India, 110070.
Saraya A; Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, India, 110029.
Sarin SK; Department of Hepatology and Liver Transplantation, Institute of Liver and Biliary Sciences, New Delhi, India, 110070. .
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 May; Vol. 68 (5), pp. 2149-2157. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Hypertension, Portal*/diagnosis
Hypertension, Portal*/etiology
Hepatitis C*
Hepatitis B*
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Elasticity Imaging Techniques*
Male ; Humans ; Adult ; Middle Aged ; Female ; Liver Cirrhosis/diagnosis ; Retrospective Studies ; Liver/diagnostic imaging
Czasopismo naukowe
Szczegóły
Tytuł:
Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
Autorzy:
Unalp-Arida A; Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Two Democracy Plaza, Room 6009, 6707 Democracy Blvd., Bethesda, MD, 20892-5458, USA.
Ruhl CE; Social & Scientific Systems, Inc., a DLH Holdings Corp Company, 8757 Georgia Avenue, 12th Floor, Silver Spring, MD, 20910, USA. .
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 Apr; Vol. 68 (4), pp. 1237-1252. Date of Electronic Publication: 2022 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Elasticity Imaging Techniques*
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/epidemiology
Non-alcoholic Fatty Liver Disease*/complications
Male ; Humans ; Female ; United States/epidemiology ; Nutrition Surveys ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/epidemiology ; Prevalence ; Liver/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of strain elastography and shear wave elastography in diagnosis of fibrosis in nonalcoholic fatty liver disease.
Autorzy:
Ogino Y; Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), School of Medicine, Faculty of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.
Wakui N; Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), School of Medicine, Faculty of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan. .
Nagai H; Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), School of Medicine, Faculty of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.
Matsuda T; Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), School of Medicine, Faculty of Medicine, Toho University, 6-11-1 Omori-Nishi, Ota-Ku, Tokyo, 143-8541, Japan.
Pokaż więcej
Źródło:
Journal of medical ultrasonics (2001) [J Med Ultrason (2001)] 2023 Apr; Vol. 50 (2), pp. 187-195. Date of Electronic Publication: 2023 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*/methods
Male ; Humans ; Female ; Adult ; Middle Aged ; Aged ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/pathology ; Fibrosis ; Liver/diagnostic imaging ; Liver/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease.
Autorzy:
Basheer M; Internal Medicine Department, Galilee Medical Center, Nahariya, Israel.
Naffaa M; Rheumatology Unit, Galilee Medical Center, Nahariya, Israel.
Assy N; Internal Medicine Department, Galilee Medical Center, Nahariya, Israel.; Rheumatology Unit, Galilee Medical Center, Nahariya, Israel.; Azrieli Faculty of Medicine in the Galilee, Bar-Ilan, University, Safed, Israel.
Pokaż więcej
Źródło:
Clinical and molecular hepatology [Clin Mol Hepatol] 2023 Apr; Vol. 29 (2), pp. 398-400. Date of Electronic Publication: 2023 Feb 13.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Liver/pathology ; Biomarkers/blood
Opinia redakcyjna
Szczegóły
Tytuł:
Fibro-Scope V1.0.1: an artificial intelligence/neural network system for staging of nonalcoholic steatohepatitis.
Autorzy:
Yamaguchi K; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Shima T; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, 1-2 Kawazono-cho Suita, Osaka, 564-0013, Japan.
Mitsumoto Y; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, 1-2 Kawazono-cho Suita, Osaka, 564-0013, Japan.
Seko Y; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Umemura A; Department of Pharmacology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Itoh Y; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakajima A; Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kaneko S; Department of Gastroenterology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan.
Harada K; Department of Human Pathology, Graduate School of Medicine, Kanazawa University, Kanazawa, Japan.
Watkins T; Clinical Development, Gilead Sciences, Inc., Foster City, USA.
Okanoue T; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, 1-2 Kawazono-cho Suita, Osaka, 564-0013, Japan. .
Pokaż więcej
Źródło:
Hepatology international [Hepatol Int] 2023 Jun; Vol. 17 (3), pp. 573-583. Date of Electronic Publication: 2022 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Humans ; Artificial Intelligence ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Fibrosis ; Neural Networks, Computer ; Liver/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.
Autorzy:
Dahmus J; Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.
Hummer B; Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.
Rivas G; Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.
Schmitz K; Department of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.; Cancer Institute, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.; Department of Kinesiology, The Pennsylvania State University - College of Medicine, Hershey, PA, USA.; Department of Physical Medicine & Rehabilitation, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Caldwell SH; Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Argo CK; Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia, Charlottesville, VA, USA.
Schreibman I; Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.; Liver Center, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.
Stine JG; Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA. .; Department of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA. .; Cancer Institute, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA. .; Liver Center, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA. .
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 Jun; Vol. 68 (6), pp. 2695-2703. Date of Electronic Publication: 2023 Jan 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/pathology
Cardiorespiratory Fitness*
Humans ; Female ; Adult ; Middle Aged ; Male ; Cross-Sectional Studies ; Liver/pathology ; Liver Cirrhosis/complications ; Fibrosis ; Biopsy
Czasopismo naukowe
Szczegóły
Tytuł:
A bioartificial transgenic porcine whole liver expressing human proteins alleviates acute liver failure in pigs.
Autorzy:
Xue WS; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
Zhang HJ; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Ke JJ; People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou 350000, China.
Fu Y; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Peng Q; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Li L; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Gao Y; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou 510280, China.
Zhong KB; General Surgery Center, Department of Hepatobiliary Surgery II, Guangdong Provincial Research Center for Artificial Organ and Tissue Engineering, Guangzhou Clinical Research and Transformation Center for Artificial Liver, Institute of Regenerative Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. Electronic address: .
Pokaż więcej
Źródło:
Hepatobiliary & pancreatic diseases international : HBPD INT [Hepatobiliary Pancreat Dis Int] 2023 Jun; Vol. 22 (3), pp. 270-281. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Liver, Artificial*
Liver Failure, Acute*/therapy
Liver Failure*
Animals ; Swine ; Humans ; Animals, Genetically Modified ; Liver
Czasopismo naukowe
Szczegóły
Tytuł:
Multiparametric MR assessment of liver fat, iron, and fibrosis: a concise overview of the liver "Triple Screen".
Autorzy:
Low G; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Ferguson C; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Locas S; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Tu W; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Manolea F; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Sam M; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada.
Wilson MP; Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, WMC 2B2.41 8440-112 ST, Edmonton, AB, T6G2B7, Canada. .
Pokaż więcej
Źródło:
Abdominal radiology (New York) [Abdom Radiol (NY)] 2023 Jun; Vol. 48 (6), pp. 2060-2073. Date of Electronic Publication: 2023 Apr 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*/methods
Humans ; Iron ; Liver/diagnostic imaging ; Liver/pathology ; Magnetic Resonance Imaging/methods ; Biomarkers ; Fibrosis
Czasopismo naukowe
Szczegóły
Tytuł:
Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C.
Autorzy:
Wang CL; Cardiovascular Division, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, No. 5 Fu-Shin Street, Kwei-Shan District, Taoyuan, 33305, Taiwan.; College of Medicine, Chang-Gung University, Taoyuan, Taiwan.
Huang CH; College of Medicine, Chang-Gung University, Taoyuan, Taiwan.; Division of Hepatology, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Wu VC; Cardiovascular Division, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, No. 5 Fu-Shin Street, Kwei-Shan District, Taoyuan, 33305, Taiwan.; College of Medicine, Chang-Gung University, Taoyuan, Taiwan.
Wu CL; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Huang YT; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.; Graduate Institute of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan.
Chang SH; Cardiovascular Division, Department of Internal Medicine, Linkou Medical Center, Chang Gung Memorial Hospital, No. 5 Fu-Shin Street, Kwei-Shan District, Taoyuan, 33305, Taiwan. .; College of Medicine, Chang-Gung University, Taoyuan, Taiwan. .; Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan. .; Graduate Institute of Nursing, Chang Gung University of Science and Technology, Taoyuan, Taiwan. .
Pokaż więcej
Źródło:
Digestive diseases and sciences [Dig Dis Sci] 2023 Jun; Vol. 68 (6), pp. 2747-2756. Date of Electronic Publication: 2023 Apr 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/pathology
Elasticity Imaging Techniques*
Non-alcoholic Fatty Liver Disease*/epidemiology
Cardiovascular Diseases*/complications
Humans ; Prognosis ; Retrospective Studies ; Liver Cirrhosis/complications ; Liver/diagnostic imaging ; Liver/pathology ; Biopsy/adverse effects
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 1086891

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies